<DOC>
	<DOCNO>NCT01187394</DOCNO>
	<brief_summary>In Canada , 218,000 unit fresh frozen plasma frozen plasma transfuse 2005.Cardiac surgery patient large recipient group FP transfusion . Despite , study characterize use FP relation coagulation test abnormality bleed , clinical determinant influence decision transfuse FP . Furthermore , study evaluate effectiveness FP transfusion correct laboratory abnormality treat bleed cardiac surgery . Given vary use FP transfusion cardiac surgery , study essential.In order improve current utilization FP , current use must understand , relationship FP transfusion clinical factor affect decision transfuse FP .</brief_summary>
	<brief_title>Plasma Utilization Following Cardiac Surgery</brief_title>
	<detailed_description>This study examine ( 1 ) utilization pattern use FP transfusion , ( 2 ) clinical determinant influence physician 's decision transfuse blood loss ( 3 ) coagulation test individual cardiac surgery patient . Through great understanding current use FP cardiovascular surgery , improve utilization reduce unnecessary harmful exposure blood product . Objectives : We describe incidence clinical determinant FP transfusion cardiac surgery . Secondarily , evaluate relationship utilization FP transfusion ( 1 ) blood loss ( 2 ) coagulation test result . Methods : All FP transfusion give cardiac surgery patient intra postoperatively intensive care unit review . At time transfusion ( intraop ) request ( postop ) FP physicians complete short questionnaire evaluate clinical factor influence decision transfuse . For sample postoperative patient elevate INR transfuse FP , physicians complete similar short questionnaire evaluate clinical factor . Charts cardiac surgery patient review capture baseline , intraoperative postoperative data include demographic , transfusion , blood loss laboratory result . Charts patient INR &gt; 1.2 and/or receive FP review detail collect baseline data , intraoperative data , detail post operative data include FP transfusion , blood transfusion , blood loss , lab coagulation result , adverse transfusion reaction . Data collect duration stay intensive care . Outcomes : The primary outcome ( ) proportion patient transfuse FP dose FP transfuse ( 2 ) importance clinical determinant influence decision transfuse FP . Secondary outcome include measure blood loss ( mediastinal chest tube blood loss , change hemoglobin number red blood cell transfusion ) , change coagulation test result ( INR , PTT ) , frequency adverse transfusion reaction , length ICU hospital stay , mortality . Analysis : The primary analysis descriptive analysis FP transfusion clinical determinant influence decision transfuse FP . A multivariable logistic regression analysis perform examine variable associate FP utilization include postoperative IN , hemoglobin , red cell transfusion mediastinal chest tube loss patient transfuse FP . The correlation physician report clinical determinant FP transfusion blood loss coagulation test result examine Spearman Pearson correlation appropriate , multiple logistic regression . For analysis secondary outcome , mean change blood loss coagulation test result follow FP transfusion calculate , multivariable regression analysis perform examine relationship blood loss , FP transfusion change INR .</detailed_description>
	<criteria>*All subject undergo Cardiopulmonary Bypass surgery More detailed Data Collection subject : either receive least one Frozen Plasma Transfusion INR &gt; 1.2 72 hour follow surgery admit intensive care unit . No subject undergo cardiopulmonary bypass surgery exclude</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Frozen Plasma</keyword>
	<keyword>Fresh Frozen Plasma</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Bleeding</keyword>
	<keyword>Knowledge Translation</keyword>
</DOC>